brand semaglutide US FDA approves weight loss drug Wegovy to prevent cardiovascular events Should I Get Compounded Semaglutide

Description

In its 'summary of risk management plan for Ozempic', the EMA revealed it had identified an 'important' risk of diabetic retinopathy complications, following a 2021 trial of the drug

Gastrointestinal motility changes represent a primary concern

Distinguishing features that suggest inflammatory bowel conditions rather than expected Wegovy side effects include: Blood in stools (though some forms of colitis, such as microscopic colitis, typically present with persistent non-bloody diarrhoea) Persistent nocturnal diarrhoea disrupting sleep Severe, unremitting abdominal pain Unintentional weight loss beyond expected therapeutic effects Fever accompanying gastrointestinal symptoms Elevated inflammatory markers (CRP, ESR) or faecal calprotectin Progressive worsening rather than improvement over time Recognising these distinctions enables appropriate clinical decision-making regarding symptom management versus further investigation